The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 106-111

  Biezeveld, M ^a   Geissler, J ^a   Merkus, M ^b   Kuipers, I M ^a   Ottenkamp, J ^a,c   Kuijpers, T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fc gamma receptors; Intravenous immunoglobulin; Kawasaki disease; Single uncleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; FC RECEPTOR; IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNE SYSTEM; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; RISK FACTORS;

EID: 33845481441     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03266.x     Document Type: Article

References (40)

1. Kawasaki T, Kosaki F, Okawa S et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-6.
2. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967; 16:178-222.
3. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
4. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324:1633-9.
5. Tse SM, Silverman ED, McCrindle BW et al. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2002; 140:450-5.
6. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001; 19:275-90.
7. Deo YM, Graziano RF, Repp R, van de Winkel JG. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol Today 1997; 18:127-35.
8. Galon J, Robertson MW, Galinha A et al. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation. Eur J Immunol 1997; 27:1928-32.
9. Maenaka K, van der Merwe PA, Stuart DI, Jones EY, Sondermann P. The human low affinity Fcgamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J Biol Chem 2001; 276:44898-904.
10. Maxwell KF, Powell MS, Hulett MD et al. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol 1999; 6:437-42.
11. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 1991; 147:1338-43.
12. Li X, Wu J, Carter RH, Edberg JC et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003; 48:3242-52.
13. Koene HR, Kleijer M, Algra J, von Roos D, dem Borne AE, de Haas M. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 1997; 90:1109-14.
14. de Haas M, Kleijer M, van Zwieten R, von Roos D, dem Borne AE. Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995; 86:2403-13.
15. Bredius RG, Derkx BH, Fijen CA et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994; 170:848-53.
16. Norris CF, Surrey S, Bunin GR, Schwartz E, Buchanan GR, McKenzie SE. Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease. J Pediatr 1996; 128:813-9.
17. Manger K, Repp R, Spriewald BM et al. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum 1998; 41:1181-9.
18. Karassa FB, Trikalinos TA, Ioannidis JP. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: ameta-analysis. FcgammaRIIa, SLE Meta-Analysis Investigators. Arthritis Rheum 2002; 46:1563-71.
19. Kyogoku C, Tsuchiya N, Wu H, Tsao BP, Tokunaga K. Association of Fcgamma receptor IIA, but not IIB and IIIA, polymorphisms with systemic lupus erythematosus: a family-based association study in Caucasians. Arthritis Rheum 2004; 50:671-3.
20. Atsumi T, Caliz R, Amengual O, Khamashta MA, Hughes GR. Fcgamma receptor IIA H/R131 polymorphism in patients with antiphospholipid antibodies. Thromb Haemost 1998; 79:924-7.
21. Carlsson LE, Santoso S, Baurichter G et al. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood 1998; 92:1526-31.
22. Dijstelbloem HM, Scheepers RH, Oost WW et al. Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum 1999; 42:1823-7.
23. Tse WY, Abadeh S, McTiernan A, Jefferis R, Savage CO, Adu D. No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol 1999; 117:198-205.
24. van der Pol WL, van den Berg LH, Scheepers RH et al. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome. Neurology 2000; 54:1661-5.
25. Brun JG, Madland TM, Vedeler CA. Immunoglobulin G fc-receptor (FcgammaR) IIA IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. J Rheumatol 2002; 29:1135-40.
26. Taniuchi S, Masuda M, Teraguchi M et al. Polymorphisms of Fcgamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol 2005 July; 25:309-13.
27. Kyogoku C, Dijstelbloem HM, Tsuchiya N et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002; 46:1242-54.
28. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Kawase H, Sekine I. Regulation of the expression of Fc gamma receptor on circulating neutrophils and monocytes in Kawasaki disease. Clin Exp Immunol 1999; 117:418-22.
29. Platonov AE, Shipulin GA, Vershinina IV,Dankert J, van de Winkel JG, Kuijper EJ. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis 1998; 27:746-50.
30. Fijen CA, Bredius RG, Kuijper EJ et al. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol 2000; 120:338-45.
31. Domingo P, Muniz-Diaz E, Baraldes MA et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med 2002; 112:19-25.
32. Abadi J, Zhong Z, Dobroszycki J, Pirofski LA. Fc gammaRIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease. Pediatr Res 1997; 42:259-62.
33. Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30:25-8.
34. Magnusson V, Zunec R, Odeberg J et al. Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population. Arthritis Rheum 2004; 50:1348-50.
35. Bruin M, Bierings M, Uiterwaal C et al. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study. Br J Haematol 2004; 127:561-7.
36. Wainstein E, Edberg J, Csernok E et al. FcγRIIIB alleles predict renal dysfunction in Wegener's granulomatosis (WG). Arthritis Rheum 1996; 39:S210.
37. Tse WY, Abadeh S, Jefferis R, Savage COS, Adu D. Neutrophil FcγRIIIB allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol 2000; 119:574-7.
38. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291:484-6.
39. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290:84-9.
40. Clatworthy MR, Smith KGC. FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 2004; 199:717-23.